224 related articles for article (PubMed ID: 18299485)
1. Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response.
Fraccarollo D; Galuppo P; Schraut S; Kneitz S; van Rooijen N; Ertl G; Bauersachs J
Hypertension; 2008 Apr; 51(4):905-14. PubMed ID: 18299485
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
[TBL] [Abstract][Full Text] [Related]
3. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
Fraccarollo D; Galuppo P; Schmidt I; Ertl G; Bauersachs J
Cardiovasc Res; 2005 Jul; 67(1):97-105. PubMed ID: 15949473
[TBL] [Abstract][Full Text] [Related]
4. Effects of eplerenone on transcriptional factors and mRNA expression related to cardiac remodelling after myocardial infarction.
Enomoto S; Yoshiyama M; Omura T; Matsumoto R; Kusuyama T; Kim S; Izumi Y; Akioka K; Iwao H; Takeuchi K; Yoshikawa J
Heart; 2005 Dec; 91(12):1595-600. PubMed ID: 15797934
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of mineralocorticoid receptor antagonism in the acute myocardial infarction phase: eplerenone versus spironolactone.
Fraccarollo D; Galuppo P; Sieweke JT; Napp LC; Grobbecker P; Bauersachs J
ESC Heart Fail; 2015 Sep; 2(3):150-158. PubMed ID: 28834677
[TBL] [Abstract][Full Text] [Related]
6. Effect of a selective aldosterone receptor antagonist in myocardial infarction.
Delyani JA; Robinson EL; Rudolph AE
Am J Physiol Heart Circ Physiol; 2001 Aug; 281(2):H647-54. PubMed ID: 11454568
[TBL] [Abstract][Full Text] [Related]
7. Eplerenone, a selective aldosterone blocker, improves diastolic function in aged rats with small-to-moderate myocardial infarction.
Masson S; Staszewsky L; Annoni G; Carlo E; Arosio B; Bai A; Calabresi C; Martinoli E; Salio M; Fiordaliso F; Scanziani E; Rudolph AE; Latini R
J Card Fail; 2004 Oct; 10(5):433-41. PubMed ID: 15470655
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of eplerenone in the rat heart: interaction with locally synthesized or blood-derived aldosterone?
Chai W; Garrelds IM; de Vries R; Danser AH
Hypertension; 2006 Apr; 47(4):665-70. PubMed ID: 16490840
[TBL] [Abstract][Full Text] [Related]
9. Macrophage Mineralocorticoid Receptor Is a Pleiotropic Modulator of Myocardial Infarct Healing.
Fraccarollo D; Thomas S; Scholz CJ; Hilfiker-Kleiner D; Galuppo P; Bauersachs J
Hypertension; 2019 Jan; 73(1):102-111. PubMed ID: 30543467
[TBL] [Abstract][Full Text] [Related]
10. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction.
Maekawa Y; Anzai T; Yoshikawa T; Sugano Y; Mahara K; Kohno T; Takahashi T; Ogawa S
J Am Coll Cardiol; 2004 Oct; 44(7):1510-20. PubMed ID: 15464336
[TBL] [Abstract][Full Text] [Related]
11. Effects of eplerenone, a selective aldosterone blocker, on the progression of left ventricular dysfunction and remodeling in rats with dilated cardiomyopathy.
Wahed MI; Watanabe K; Ma M; Yamaguchi K; Takahashi T; Tachikawa H; Kodama M; Aizawa Y
Pharmacology; 2005 Feb; 73(2):81-8. PubMed ID: 15467302
[TBL] [Abstract][Full Text] [Related]
12. Eplerenone-mediated regression of electrical activation delays and myocardial fibrosis in heart failure.
J Cardiovasc Electrophysiol; 2014 May; 25(5):556-577. PubMed ID: 24612029
[TBL] [Abstract][Full Text] [Related]
13. Collagen accumulation after myocardial infarction: effects of ETA receptor blockade and implications for early remodeling.
Fraccarollo D; Galuppo P; Bauersachs J; Ertl G
Cardiovasc Res; 2002 Jun; 54(3):559-67. PubMed ID: 12031701
[TBL] [Abstract][Full Text] [Related]
14. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
[TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction.
Lax A; Sanchez-Mas J; Asensio-Lopez MC; Fernandez-Del Palacio MJ; Caballero L; Garrido IP; Pastor-Perez FJ; Januzzi JL; Pascual-Figal DA
JACC Heart Fail; 2015 Jan; 3(1):50-58. PubMed ID: 25458175
[TBL] [Abstract][Full Text] [Related]
16. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
Takeda M; Tatsumi T; Matsunaga S; Hayashi H; Kimata M; Honsho S; Nishikawa S; Mano A; Shiraishi J; Yamada H; Takahashi T; Matoba S; Kobara M; Matsubara H
Hypertens Res; 2007 May; 30(5):427-37. PubMed ID: 17587755
[TBL] [Abstract][Full Text] [Related]
17. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling.
Kohno T; Anzai T; Naito K; Miyasho T; Okamoto M; Yokota H; Yamada S; Maekawa Y; Takahashi T; Yoshikawa T; Ishizaka A; Ogawa S
Cardiovasc Res; 2009 Feb; 81(3):565-73. PubMed ID: 18984601
[TBL] [Abstract][Full Text] [Related]
18. Elevated cardiac tissue level of aldosterone and mineralocorticoid receptor in diastolic heart failure: Beneficial effects of mineralocorticoid receptor blocker.
Ohtani T; Ohta M; Yamamoto K; Mano T; Sakata Y; Nishio M; Takeda Y; Yoshida J; Miwa T; Okamoto M; Masuyama T; Nonaka Y; Hori M
Am J Physiol Regul Integr Comp Physiol; 2007 Feb; 292(2):R946-54. PubMed ID: 17023667
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
Sandmann S; Li J; Fritzenkötter C; Spormann J; Tiede K; Fischer JW; Unger T
Blood Press; 2006; 15(2):116-28. PubMed ID: 16754275
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of selective mineralocorticoid receptor antagonist against aortic aneurysm progression in a novel murine model.
Kurobe H; Hirata Y; Matsuoka Y; Sugasawa N; Higashida M; Nakayama T; Maxfield MW; Yoshida Y; Shimabukuro M; Kitagawa T; Sata M
J Surg Res; 2013 Nov; 185(1):455-62. PubMed ID: 23731681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
